Last updated: December 9, 2024
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Carotid Artery Disease
Treatment
Gao's triple eversion carotid endarterectomy
Clinical Study ID
NCT06722222
2024-1043
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Meet the diagnostic criteria for TCL stenosis.
Above 70% asymptomatic CCA and ICA stenosis or > 50% symptomatic CAS confirmed byDSA or CTA before surgery
Exclusion
Exclusion Criteria:
Did not meet the diagnostic criteria for CAS
Asymptomatic CAS < 50% (as confirmed by DSA or CTA before surgery)
With stenosis at the opening of the CCA.
Study Design
Total Participants: 11
Treatment Group(s): 1
Primary Treatment: Gao's triple eversion carotid endarterectomy
Phase:
Study Start date:
September 17, 2021
Estimated Completion Date:
September 20, 2031
Study Description
Connect with a study center
the Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang 310050
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.